<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Parkinson on VitaminDWiki</title>
    <link>http://localhost:1313/categories/parkinson/</link>
    <description>Recent content in Parkinson on VitaminDWiki</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Thu, 04 Jan 2024 00:00:00 +0000</lastBuildDate>
    <atom:link href="http://localhost:1313/categories/parkinson/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Risk of Parkinson’s decreases with time in summer sun</title>
      <link>http://localhost:1313/posts/risk-of-parkinsons-decreases-with-time-in-summer-sun/</link>
      <pubDate>Thu, 04 Jan 2024 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/risk-of-parkinsons-decreases-with-time-in-summer-sun/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;association-of-time-spent-outdoors-with-the-risk-of-parkinsons-disease-a-prospective-cohort-study-of-329359-participants&#34;&gt;Association of time spent outdoors with the risk of Parkinson&amp;rsquo;s disease: a prospective cohort study of 329,359 participants&lt;/h4&gt;&#xA;&lt;p&gt;BMC Neurol. 2024 Jan 2;24(1):10. &lt;a href=&#34;https://doi.org/10.1186/s12883-023-03499-7.&#34;&gt;doi: 10.1186/s12883-023-03499-7.&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Ling Hu # 1, Yisen Shi # 2 3, Xinyang Zou 2 3, Zhaohui Lai 1, Fabin Lin 4, Guoen Cai 5, Xianghong Liu 6&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;400&#34;&gt;&#xA;&lt;p&gt;16% reduced risk if outdoors for &amp;gt; 5 hrs&lt;/p&gt;&#xA;&lt;p&gt;Suspect 60% reduced risk if outdoors, lying down, with minimal clothing for 1 hour&lt;/p&gt;</description>
    </item>
    <item>
      <title>Central Nervous System protection by Vitamin D</title>
      <link>http://localhost:1313/posts/central-nervous-system-protection-by-vitamin-d/</link>
      <pubDate>Thu, 21 Dec 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/central-nervous-system-protection-by-vitamin-d/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;molecular-regulation-of-the-cns-by-vitamin-d&#34;&gt;Molecular Regulation of the CNS by Vitamin D&lt;/h4&gt;&#xA;&lt;p&gt;Physiol Res 2023 Dec 17;72(S4):S339-S356.&lt;/p&gt;&#xA;&lt;p&gt;L Máčová 1, R Kancheva, M Bičíková&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;800&#34;&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;800&#34;&gt;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&#34;color:orange;&#34;&gt;Factors that are up-regulated are marked in green&lt;/span&gt;%%%  &lt;span style=&#34;color:orange;&#34;&gt;factors that are down-regulated are in red&lt;/span&gt;.&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;Vitamin D is a lipid-soluble vitamin that can be found in some foods. It is also produced endogenously (in the presence of ultraviolet light), transported through the blood to the targets organs and this is the reason to consider vitamin D as a hormone. It is known that vitamin D has genomic and non-genomic effects.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Many Neurological Diseases fought by Vitamin D</title>
      <link>http://localhost:1313/posts/many-neurological-diseases-fought-by-vitamin-d/</link>
      <pubDate>Thu, 26 Oct 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/many-neurological-diseases-fought-by-vitamin-d/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d-in-neurological-diseases&#34;&gt;Vitamin D in Neurological Diseases&lt;/h4&gt;&#xA;&lt;p&gt;Int. J. Mol. Sci. 2023, 24(1), 87; &lt;a href=&#34;https://doi.org/10.3390/ijms24010087&#34;&gt;https://doi.org/10.3390/ijms24010087&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;by Domenico Plantone 1,*ORCID,Guido Primiano 2,3ORCID,Carlo Manco 1,Sara Locci 1,Serenella Servidei 2,3ORCID andNicola De Stefano 1&lt;/p&gt;&#xA;&lt;p&gt;1 Centre for Precision and Translational Medicine, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy&lt;/p&gt;&#xA;&lt;p&gt;2 Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy&lt;/p&gt;&#xA;&lt;p&gt;3 Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, 00168 Rome, Italy&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson’s disease: Review of low-dose vitamin D RCTs found small benefit</title>
      <link>http://localhost:1313/posts/parkinsons-disease-review-of-low-dose-vitamin-d-rcts-found-small-benefit/</link>
      <pubDate>Fri, 06 Oct 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-disease-review-of-low-dose-vitamin-d-rcts-found-small-benefit/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d-in-parkinsons-disease-a-systematic-review-of-randomized-controlled-trials&#34;&gt;Vitamin D in Parkinson’s disease: A systematic review of randomized controlled trials.&lt;/h4&gt;&#xA;&lt;p&gt;Clinical Nutrition Open Science Available online 28 September 2023 &lt;a href=&#34;https://doi.org/10.1016/j.nutos.2023.09.005&#34;&gt;https://doi.org/10.1016/j.nutos.2023.09.005&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Paraskevi Detopoulou 1 3, Gavriela Voulgaridou 2, Alexandra Saridaki 1 3, Ioanna Pylarinou 3, Elissaios- Minos Argyris 1, Vasilios Dedes 3, Constantinos Giaginis 4, Georgios I. Panoutsopoulos 3, Sousana K. Papadopoulou 2&lt;/p&gt;&#xA;&lt;p&gt;In recent years, neurodegenerative diseases are a leading cause of morbidity and disability worldwide, with Parkinson&amp;rsquo;s disease (PD) being the most prevalent. Although diet and vitamin status play a crucial role in PD, the results of vitamin D supplementation are scarce and contradictory. Therefore, the present systematic work reviewed the available randomized controlled trials (RCTs) regarding the role of vitamin D supplementation in patients with PD in the Pubmed, Scopus and Cochrane databases and in grey literature. Four RCTs including 321 patients with PD were identified. Various doses of vitamin D were administered  &lt;strong&gt;(1,000- 10,000 IU/d)&lt;/strong&gt;  and different exposure outcomes were assessed. One study reported beneficial effects of vitamin D on the Hoehn and Yahr scale (HY) and two studies reported null effects on the Unified Parkinson&amp;rsquo;s Disease Rating Scale (UPDRS). Regarding functional tests, heterogeneous results in the timed-up and go (TUG) test were observed in two studies. One study conducted minute walking tests at 6 and 10 minutes and found an improvement only in the 6MWT. In conclusion, a very small number of RCTs have assessed the effects of vitamin D supplementation on PD. Some isolated beneficial effects of vitamin D were reported on functional scales and tests but more studies are needed to draw safe conclusions regarding its supplementation in PD.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson&#39;s disease prevented by Vitamin D, but small doses do not treat it</title>
      <link>http://localhost:1313/posts/parkinsons-disease-prevented-by-vitamin-d-but-small-doses-do-not-treat-it/</link>
      <pubDate>Wed, 09 Aug 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-disease-prevented-by-vitamin-d-but-small-doses-do-not-treat-it/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;does-vitamin-d-protect-or-treat-parkinsons-disease-a-narrative-review&#34;&gt;Does vitamin D protect or treat Parkinson&amp;rsquo;s disease? A narrative review&lt;/h4&gt;&#xA;&lt;p&gt;Naunyn Schmiedebergs Arch Pharmacol  2023 Aug 9.DOI: 10.1007/s00210-023-02656-6&lt;/p&gt;&#xA;&lt;p&gt;Hayder M Al-Kuraishy 1, Ali I Al-Gareeb 1, Hend Mostafa Selim 2, Athanasios Alexiou 3 4, Marios Papadakis 5, Walaa A Negm 6, Gaber El-Saber Batiha 7&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;800&#34;&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;800&#34;&gt;&#xA;&lt;p&gt;Parkinson&amp;rsquo;s disease (PD) is a neurodegenerative brain disease (NBD) developed due to dopaminergic neuron loss in the substantia nigra (SN). Vitamin D (VD), VD receptor (VDR), and VD metabolites are highly expressed in the human brain and play a critical role in maintaining different brain functions. VDRs are highly expressed in the SN that regulates the activity of dopaminergic neurons and synaptic plasticity. VD exerts protective and therapeutic effects against the development of PD by modulating dopaminergic neurons of SN. VD reduces oxidative stress and neuroinflammation in PD because of its anti-inflammatory and antioxidant activities. Different studies revealed the protective effect of VD in the management of PD. However, the potential therapeutic effect of VD in well-established PD remains controversial. Therefore, this review aims to elucidate VD&amp;rsquo;s preventive and therapeutic roles in PD.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Global burden of brain disorders surpasses cardiovascular disease and cancer</title>
      <link>http://localhost:1313/posts/global-burden-of-brain-disorders-surpasses-cardiovascular-disease-and-cancer/</link>
      <pubDate>Sat, 15 Jul 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/global-burden-of-brain-disorders-surpasses-cardiovascular-disease-and-cancer/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;from-mdedgehttpswwwmdedgecomneurologyarticle264086neurologyglobal-burden-brain-disorders-surpasses-cardiovascular-diseaseecdwnl_eve_230715_mdedge&#34;&gt;From &lt;a href=&#34;https://www.mdedge.com/neurology/article/264086/neurology/global-burden-brain-disorders-surpasses-cardiovascular-disease?ecd=WNL_EVE_230715_mdedge&#34;&gt;MDEdge&lt;/a&gt;&lt;/h4&gt;&#xA;&lt;p&gt;Brain disorders, including mental illness, neurologic conditions, and stroke, account for more than 15% of all health loss worldwide – more than either cardiovascular disease or cancer – at huge cost to health care systems and society, an analysis of data from the most recent Global Burden of Disease (GBD) study shows.&lt;/p&gt;&#xA;&lt;p&gt;“The burden of brain conditions will increase as populations continue to grow and age,” said study presenter Shayla Smith, MPH, an epidemiologist at the Institute for Health Metrics and Evaluation, the University of Washington, Seattle, in a press release.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson’s – Vitamin D, bone and falls</title>
      <link>http://localhost:1313/posts/parkinsons-vitamin-d-bone-and-falls/</link>
      <pubDate>Wed, 10 May 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-vitamin-d-bone-and-falls/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;the-relationship-among-bone-mineral-density-bone-biomarkers-and-vitamin-d-levels-in-patients-with-parkinsons-disease&#34;&gt;The Relationship Among Bone Mineral Density, Bone Biomarkers and Vitamin D Levels in Patients with Parkinson&amp;rsquo;s Disease.&lt;/h4&gt;&#xA;&lt;p&gt;Clinical Laboratory, 01 Aug 2020, 66(8) DOI: 10.7754/clin.lab.2019.190615 PDF is behind a paywall&lt;/p&gt;&#xA;&lt;p&gt;Can NU, Alagöz AN&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Idiopathic Parkinson&amp;rsquo;s disease (IPD)&lt;/strong&gt;  is the most common age-related neurodegenerative movement disorder. It causes a decrease and deceleration in movements. It may also lead to loss of bone mineral density, vitamin D deficiency, falls and fractures due to various factors. As indicated in our study, determining the prevalence of osteopenia and osteoporosis in IPD is important to determine complications.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson’s Disease and Vitamin D – review of 52 studies</title>
      <link>http://localhost:1313/posts/parkinsons-disease-and-vitamin-d-review-of-52-studies/</link>
      <pubDate>Wed, 10 May 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-disease-and-vitamin-d-review-of-52-studies/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d-and-parkinsons-disease&#34;&gt;Vitamin D and Parkinson’s Disease&lt;/h4&gt;&#xA;&lt;p&gt;Nutrients  Volume 14  Issue 6  10.3390/nu14061220&lt;/p&gt;&#xA;&lt;p&gt;Antonia Pignolo 1ORCID,Sergio Mastrilli 1,Chiara Davì 1ORCID,Valentina Arnao 2,Paolo Aridon 1,Felipe Augusto dos Santos Mendes 3ORCID,Cesare Gagliardo 1ORCID andMarco D’Amelio 1,*&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;1 Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;2 UO Neurologia e Stroke Unit, Azienda di Rilievo Nazionale ad Alta Specializzazione, Ospedali Civico Di Cristina Benfratelli, 90134 Palermo, Italy&lt;/p&gt;</description>
    </item>
    <item>
      <title>How Vitamin D fights Alzheimer’s, Parkinson’s, Multiple Sclerosis and Epilepsy</title>
      <link>http://localhost:1313/posts/how-vitamin-d-fights-alzheimers-parkinsons-multiple-sclerosis-and-epilepsy/</link>
      <pubDate>Sat, 22 Apr 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/how-vitamin-d-fights-alzheimers-parkinsons-multiple-sclerosis-and-epilepsy/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;molecular-insights-into-the-pathogenic-impact-of-vitamin-d-deficiency-in-neurological-disorders&#34;&gt;Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders&lt;/h4&gt;&#xA;&lt;p&gt;Biomed Pharmacother. 2023 Apr 19;162:114718. &lt;a href=&#34;https://doi.org/10.1016/j.biopha.2023.114718&#34;&gt;doi: 10.1016/j.biopha.2023.114718&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Md Jamir Anwar 1, Sattam Khulaif Alenezi 2, Ahmad Hamad Alhowail 3&lt;/p&gt;&#xA;&lt;h5 id=&#34;charts-of-impact-of-vitamin-d&#34;&gt;Charts of impact of Vitamin D&lt;/h5&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;900&#34;&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;900&#34;&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;900&#34;&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;900&#34;&gt;&#xA;&lt;p&gt;&lt;strong&gt;PDF Table of Contents&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;600&#34;&gt;&#xA;&lt;p&gt;Neurological disorders are the major cause of disability, leading to a decrease in quality of life by impairing cognitive, sensorimotor, and motor functioning. Several factors have been proposed in the pathogenesis of neurobehavioral changes, including nutritional, environmental, and genetic predisposition. Vitamin D (VD) is an environmental and nutritional factor that is widely distributed in the central nervous system&amp;rsquo;s subcortical grey matter, neurons of the substantia nigra, hippocampus, thalamus, and hypothalamus. It is implicated in the regulation of several brain functions by preserving neuronal structures. It is a hormone rather than a nutritional vitamin that exerts a regulatory role in the pathophysiology of several neurological disorders, including Alzheimer&amp;rsquo;s disease, Parkinson&amp;rsquo;s disease, epilepsy, and multiple sclerosis.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson&#39;s Disease 25 percent more likely if air pollution (likely lower Vitamin D)</title>
      <link>http://localhost:1313/posts/parkinsons-disease-25-percent-more-likely-if-air-pollution-likely-lower-vitamin-d/</link>
      <pubDate>Tue, 11 Apr 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-disease-25-percent-more-likely-if-air-pollution-likely-lower-vitamin-d/</guid>
      <description>&lt;!-- {maketoc Title=&#34;&#34;} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;mississippiohio-river-valley-linked-to-higher-risk-of-parkinsons-disease&#34;&gt;Mississippi–Ohio River valley linked to higher risk of Parkinson’s disease&lt;/h4&gt;&#xA;&lt;p&gt;&lt;strong&gt;&lt;a href=&#34;https://www.mdedge.com/neurology/article/262306/parkinsons-disease/mississippi-ohio-river-valley-linked-higher-risk?ecd=WNL_EVE_230411_mdedge&#34;&gt;MDEdge&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&amp;ldquo;In total, researchers identified 83,674 Medicare beneficiaries with incident Parkinson’s disease, with  &lt;strong&gt;434&lt;/strong&gt;  new cases per 100,000 people in the highest exposure group, compared with  &lt;strong&gt;359&lt;/strong&gt;  new cases per 100,000 people in the lowest-exposure group. The relative risk for Parkinson’s disease increased in the highest quartile of PM2.5 by 25%, compared with the lowest quartile after adjusting for factors such as age, smoking status, and health care usage (95% confidence interval, 20%–29%).&amp;rdquo;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;&lt;strong&gt;Comment by VitaminDWiki%%%Due to less getting outdoors due to air pollution and less vitamin D from the sun due to the pollution&lt;/strong&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson&#39;s Disease 5X more likely if Trichloroethylene (TCE, wonder about Vit D)</title>
      <link>http://localhost:1313/posts/parkinsons-disease-5x-more-likely-if-trichloroethylene-tce-wonder-about-vit-d/</link>
      <pubDate>Fri, 24 Mar 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-disease-5x-more-likely-if-trichloroethylene-tce-wonder-about-vit-d/</guid>
      <description>&lt;!-- {maketoc} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;trichloroethylene-an-invisible-cause-of-parkinsons-disease&#34;&gt;Trichloroethylene: An Invisible Cause of Parkinson’s Disease?&lt;/h4&gt;&#xA;&lt;p&gt;Journal of Parkinson&amp;rsquo;s Disease, vol. 13, no. 2, pp. 203-218, 2023 DOI: 10.3233/JPD-225047&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Dorsey&lt;/strong&gt; , E. Raya; b; 1; * | Zafar, Maryama; 1 | Lettenberger, Samantha E.a | Pawlik, Meghan E.a | Kinel, Dana; b | Frissen, Myrthec | Schneider, Ruth B.a; b | Kieburtz, Karla; b | Tanner, Caroline M.d | De Miranda, Briana R.e | Goldman, Samuel M.f | Bloem, Bastiaan R.c&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson’s Disease, low vitamin D and Vit. D genetics</title>
      <link>http://localhost:1313/posts/parkinsons-disease-low-vitamin-d-and-vit-d-genetics/</link>
      <pubDate>Tue, 14 Feb 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-disease-low-vitamin-d-and-vit-d-genetics/</guid>
      <description>&lt;!-- {maketoc} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d-deficiency-and-genetic-polymorphisms-of-vitamin-d-associated-genes-in-parkinsons-disease&#34;&gt;Vitamin D deficiency and genetic polymorphisms of Vitamin D-associated genes in Parkinson’s Disease&lt;/h4&gt;&#xA;&lt;p&gt;European Journal of Neuroscience preprint DOI: 10.22541/au.167407862.25881100/v1&lt;/p&gt;&#xA;&lt;p&gt;Barnali Ray Basu1, Randrita Pal1, Supriyo Choudhury2, Hrishikesh Kumar2, Sanjit Dey3, and Nilansu Das1&lt;/p&gt;&#xA;&lt;p&gt;1Surendranath College&lt;/p&gt;&#xA;&lt;p&gt;2Institute of Neurosciences Kolkata&lt;/p&gt;&#xA;&lt;p&gt;3University of Calcutta Faculty Council for Post-Graduate Studies in Science&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;800&#34;&gt;&#xA;&lt;p&gt;Parkinson’s Disease (PD) and vitamin D share a unique link as Vitamin D deficiency (VDD) prevails in PD. Thus, an in-depth understanding of Vitamin D biology in PD might be crucial for therapeutic strategies emphasizing Vitamin D. Specifically, explicating the effect of VDD and genetic polymorphisms of vitamin D-associated genes in PD, like&lt;/p&gt;</description>
    </item>
    <item>
      <title>Parkinson&#39;s Disease and gut microbiome - several studies</title>
      <link>http://localhost:1313/posts/parkinsons-disease-and-gut-microbiome-several-studies/</link>
      <pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/parkinsons-disease-and-gut-microbiome-several-studies/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Strong association, unknown cause-affect direction&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Note: Vitamin D massively changes the composiition of gut bacteria&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;&lt;a href=&#34;http://localhost:1313/posts/vitamin-d-levels-change-gut-microbiota-25-study-review&#34; style=&#34;color: red; text-decoration: underline;&#34; title=&#34;This post/category does not exist yet: Vitamin D levels change Gut Microbiota – 25 study review Sept 2021&#34;&gt;Vitamin D levels change Gut Microbiota – 25 study review Sept 2021&lt;/a&gt;&lt;/p&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;&lt;a href=&#34;http://localhost:1313/posts/gut-microbiome-massively-changed-by-weekly-vitamin-d&#34; style=&#34;color: red; text-decoration: underline;&#34; title=&#34;This post/category does not exist yet: Gut microbiome massively changed by weekly vitamin D – July 2015&#34;&gt;Gut microbiome massively changed by weekly vitamin D – July 2015&lt;/a&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title>How Vitamin D fights neurodegeneration (Multiple Sclerosis, Alzheimer’s, Dementia, etc)</title>
      <link>http://localhost:1313/posts/how-vitamin-d-fights-neurodegeneration-multiple-sclerosis-alzheimers-dementia-etc/</link>
      <pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/posts/how-vitamin-d-fights-neurodegeneration-multiple-sclerosis-alzheimers-dementia-etc/</guid>
      <description>&lt;!-- {maketoc} --&gt;&#xA;&lt;hr&gt;&#xA;&lt;h4 id=&#34;vitamin-d-and-neurodegenerative-diseases&#34;&gt;Vitamin D and neurodegenerative diseases&lt;/h4&gt;&#xA;&lt;p&gt;Heliyon &lt;a href=&#34;https://doi.org/10.1016/j.heliyon.2023.e12877&#34;&gt;https://doi.org/10.1016/j.heliyon.2023.e12877&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;Weixia Wang 1 YijinLi 1 Xianfang Meng 1&lt;/p&gt;&#xA;&lt;img src=&#34;http://localhost:1313/attachments/d3.mock.jpg&#34; alt=&#34;image&#34; width=&#34;700&#34;&gt;&#xA;&lt;p&gt;Neurodegenerative diseases, featured by progressive loss of structure or function of neurons, are considered incurable at present. Movement disorders like tremor and postural instability, cognitive or behavioral disorders such as memory impairment are the most common symptoms of them and the growing patient population of neurodegenerative diseases poses a serious threat to public health and a burden on economic development. Hence, it is vital to prevent the occurrence of the diseases and delay their progress. Vitamin D can be transformed into a hormone in vivo with both genomic and non-genomic actions, exerting diverse physiological effects.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
